Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis

This publication has 26 references indexed in Scilit:

• Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (the second National Registry of Myocardial Infarction)
  The American Journal of Cardiology, 1998
• Time to Therapy and Salvage in Myocardial Infarction 11This study was supported in part by a grant from E.I. duPont de Nemours and Company, North Billerica, Massachusetts.
  Journal of the American College of Cardiology, 1998
• Time from symptom onset to treatment and outcomes after thrombolytic therapy
  Journal of the American College of Cardiology, 1996
• Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans
  Circulation, 1995
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Time as an adjunctive agent to thrombolytic therapy
  Journal of Thrombosis and Thrombolysis, 1994
• Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models
  The American Journal of Cardiology, 1993
• A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
  Circulation, 1992
• Experimental coronary artery occlusion
  Basic Research in Cardiology, 1979
• The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.
  Circulation, 1977